Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's disease
Abstract Introduction Alzheimer's disease (AD) is associated with synapse loss. Souvenaid, containing the specific nutrient combination Fortasyn Connect, was designed to improve synapse formation and function. The NL‐ENIGMA study explored the effect of Souvenaid on synapse function in early AD...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.08.002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|